Patents by Inventor Kuang-Dee Chen

Kuang-Dee Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Industrial scale process of cultivating mycelium
    Patent number: 9820443
    Abstract: Disclosed herein is an industrial scale process of cultivating cultivating Ganoderma lucidum mycelia. As high as 15 Kg dried Ganoderma lucidum mycelia may be produced from about 300 liters liquid culture every 30 days, and the resulting dried Ganoderma lucidum mycelia are rich in triterpenoids that include at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and ganodermic acid S (GMAS).
    Type: Grant
    Filed: August 9, 2013
    Date of Patent: November 21, 2017
    Assignee: DOUBLE CRANE BIOTECHNOLOGY CO. LTD.
    Inventors: Li-Ming Huang, Chih-Wei Chen, Mon-Tarng Chen, Yen-Chun Liu, Kuang-Dee Chen
  • Compound, composition and method for treating and/or ameoliorating kidney disease
    Patent number: 9512168
    Abstract: Disclosed herein are compositions and methods for the treatment or prophylaxis of a subject having or susceptible to a kidney disease. The method includes the step of administering to the subject a compound of formula (I) in a dose of about 1 to 10 mg/Kg to improve the glomerular filtration rate (GFR) of the subject for at least 4 folds as compared to the GFR of the subject before treatment, The method further includes the step of administering to the subject an effective amount of lucidenic acid C (LAC), lucidenic acid N (LAN), lucidenic acid E2 (LAE2), lucidenic acid A (LAA), and lucidenic acid D2 (LAD2).
    Type: Grant
    Filed: June 9, 2014
    Date of Patent: December 6, 2016
    Inventors: Cheng-Po Huang, Teng-Hai Chen, Kuang Dee Chen, Chun-Tao Su
  • INDUSTRIAL SCALE PROCESS OF CULTIVATING GANODERMA LUCIDUM MYCELIUM
    Publication number: 20160044872
    Abstract: Disclosed herein is an industrial scale process of cultivating cultivating Ganoderma lucidum mycelia. As high as 15 Kg dried Ganoderma lucidum mycelia may be produced from about 300 liters liquid culture every 30 days, and the resulting dried Ganoderma lucidum mycelia are rich in triterpenoids that include at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and ganodermic acid S (GMAS).
    Type: Application
    Filed: August 9, 2013
    Publication date: February 18, 2016
    Inventors: Liu-Ming HUANG, Chih-Wei CHEN, Mon-Tarng CHEN, Yen-Chun LU, Kuang-Dee CHEN
  • COMPOUND, COMPOSITION AND METHOD FOR TREATING AND/OR AMEOLIORATING KIDNEY DISEASE
    Publication number: 20150353595
    Abstract: Disclosed herein are compositions and methods for the treatment or prophylaxis of a subject having or susceptible to a kidney disease. The method includes the step of administering to the subject a compound of formula (I) in a dose of about 1 to 10 mg/Kg to improve the glomerular filtration rate (GFR) of the subject for at least 4 folds as compared to the GFR of the subject before treatment, The method further includes the step of administering to the subject an effective amount of lucidenic acid C (LAC), lucidenic acid N (LAN), lucidenic acid E2 (LAE2), lucidenic acid A (LAA), and lucidenic acid D2 (LAD2).
    Type: Application
    Filed: June 9, 2014
    Publication date: December 10, 2015
    Applicant: Trineo Biotechnology Co. LTD.
    Inventors: Cheng-Po Huang, Teng-Hai Chen, Kuang Dee Chen, Chun-Tao Su
  • Therapeutic composition for treating cancers
    Patent number: 9198922
    Abstract: Disclosed herein is a composition that includes a novel combination of triterpenoids for the treatment or prophylaxis of a cancer. The triterpenoids includes at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and ganodermic acid S (GMAS). The composition is suitable for the treatment or prophylaxis of colon cancer, hepatic cancer, breast cancer, lung cancer or leukemia.
    Type: Grant
    Filed: May 28, 2013
    Date of Patent: December 1, 2015
    Assignee: Double Crane Biotechnology Co., Ltd.
    Inventors: Shwu-Bin Lin, Cheng-Po Huang, Teng-Hai Chen, Kuang-Dee Chen
  • Therapeutic Composition for Treating Cancers
    Publication number: 20140357604
    Abstract: Disclosed herein is a composition that includes a novel combination of triterpenoids for the treatment or prophylaxis of a cancer. The triterpenoids includes at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and ganodermic acid S (GMAS). The composition is suitable for the treatment or prophylaxis of colon cancer, hepatic cancer, breast cancer, lung cancer or leukemia.
    Type: Application
    Filed: May 28, 2013
    Publication date: December 4, 2014
    Inventors: Shwu-Bin Lin, Cheng-Po Huang, Teng-Hai Chen, Kuang-Dee Chen